Search Thermo Fisher Scientific
Gibco CTS DynaCellect Magnetic Separation System Specifications
The CTS DynaCellect Magnetic Separation System is manufactured in a state-of-the-art cGMP, ISO-certified facility to help ensure the highest quality and consistency for reproducible results. Designed to be a standalone instrument or part of a closed, integrated cell therapy manufacturing workflow, its ability to scale from small to large volumes future-proofs process development and clinical and commercial manufacturing.
Instrument specifications
| Processing time | 70–90 minutes |
Efficiency | >85% isolation |
DeltaV compatibility (OPC UA) | Yes |
Reproducibility | CV of 3% |
Purity | 95% (with Gibco CTS Dynabeads CD3/CD28) |
Viability | Unaffected |
Isolation scale | Max 1,000 mL working volume (equivalent to ~10 billion T-cells as input) |
Bead removal scale | Unlimited, verified up to 10 L |
Max. cell input | ~10 billion T-cells (1,000 mL isolation volume) |
Pump speed | 1–150 mL/min |
Rocker angle | -30° to +30° |
Rocker speed | 1–30 cpm (cycles per minute) |
Max. air pressure | 2 bar |
21 CFR Part 11 compliant | Yes, with upgrade |
Open Platform Communications–Unified Architecture (OPC-UA) compatible | Yes |
Cloud connect utility | Yes |
Touch display | 20.32 cm |
Voltage | 100–240 V AC ±10%, 50/60 Hz, 600 W |
Weight | 50 kg |
Depth | 562 mm |
Width | 749.5 mm |
Height | 485 mm with pole |
Consumables
To view specifications for consumables, such as the CTS DynaCellect Isolation Kit and CTS DynaCellect Bead Removal Kit, see Accessories.
Related resources
Bioprocessing resources
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:
Support
Events & Webinars
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals